[
  {
    "ts": null,
    "headline": "IQVIA Holdings Inc (IQV) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...",
    "summary": "IQVIA Holdings Inc (IQV) reports robust fourth-quarter performance with a 10.3% revenue increase and strategic advancements in AI and cloud technologies.",
    "url": "https://finnhub.io/api/news?id=61f3731d167919182501a75f115242fbbc3bdfce3b56b9cf0132f02dfa0f856d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770325258,
      "headline": "IQVIA Holdings Inc (IQV) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...",
      "id": 138368873,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "IQVIA Holdings Inc (IQV) reports robust fourth-quarter performance with a 10.3% revenue increase and strategic advancements in AI and cloud technologies.",
      "url": "https://finnhub.io/api/news?id=61f3731d167919182501a75f115242fbbc3bdfce3b56b9cf0132f02dfa0f856d"
    }
  },
  {
    "ts": null,
    "headline": "IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y",
    "summary": "IQV posted a fourth-quarter 2025 earnings and revenue beat with double-digit Y/Y sales growth, strong segment gains and upbeat 2026 revenue guidance.",
    "url": "https://finnhub.io/api/news?id=d3e99dba74f0ede4cb8738ea184da35705b6a3004f0b11f9686f8493fb01a43c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770311460,
      "headline": "IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y",
      "id": 138367672,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "IQV posted a fourth-quarter 2025 earnings and revenue beat with double-digit Y/Y sales growth, strong segment gains and upbeat 2026 revenue guidance.",
      "url": "https://finnhub.io/api/news?id=d3e99dba74f0ede4cb8738ea184da35705b6a3004f0b11f9686f8493fb01a43c"
    }
  },
  {
    "ts": null,
    "headline": "IQVIA (IQV) Stock Trades Down, Here Is Why",
    "summary": "Shares of clinical research company IQVIA (NYSE: IQV) fell 8.5% in the morning session after the company issued a weak full-year 2026 profit forecast that fell below Wall Street expectations.",
    "url": "https://finnhub.io/api/news?id=faf8b0ed023ec5cdfaf9ce2faf7536031517c44b177899e96f9dc558ee663f10",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770310553,
      "headline": "IQVIA (IQV) Stock Trades Down, Here Is Why",
      "id": 138366319,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "Shares of clinical research company IQVIA (NYSE: IQV) fell 8.5% in the morning session after the company issued a weak full-year 2026 profit forecast that fell below Wall Street expectations.",
      "url": "https://finnhub.io/api/news?id=faf8b0ed023ec5cdfaf9ce2faf7536031517c44b177899e96f9dc558ee663f10"
    }
  },
  {
    "ts": null,
    "headline": "IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript",
    "summary": "IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript",
    "url": "https://finnhub.io/api/news?id=452715f5290686c83b3280efd5aeb52a7fb51dfd8f94585b66d134da2a7e805f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770305060,
      "headline": "IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call Transcript",
      "id": 138367974,
      "image": "",
      "related": "IQV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=452715f5290686c83b3280efd5aeb52a7fb51dfd8f94585b66d134da2a7e805f"
    }
  },
  {
    "ts": null,
    "headline": "IQVIA Holdings Inc. 2025 Q4 - Results - Earnings Call Presentation",
    "summary": "2026-02-05. The following slide deck was published by IQVIA Holdings Inc.",
    "url": "https://finnhub.io/api/news?id=bb405d2a5ecb254f24e979546c7fba3520142075d87e4f250fa592a09f26100c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770303663,
      "headline": "IQVIA Holdings Inc. 2025 Q4 - Results - Earnings Call Presentation",
      "id": 138367773,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "IQV",
      "source": "SeekingAlpha",
      "summary": "2026-02-05. The following slide deck was published by IQVIA Holdings Inc.",
      "url": "https://finnhub.io/api/news?id=bb405d2a5ecb254f24e979546c7fba3520142075d87e4f250fa592a09f26100c"
    }
  },
  {
    "ts": null,
    "headline": "IQVIA forecasts weak annual profit on higher interest expenses",
    "summary": "Feb 5 (Reuters) - Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed down by higher interest costs, even as strong",
    "url": "https://finnhub.io/api/news?id=e765656a305790716ce0e8ee437a200beba2726e8e3a8a57cc67b8660c54a951",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770300434,
      "headline": "IQVIA forecasts weak annual profit on higher interest expenses",
      "id": 138366144,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "Feb 5 (Reuters) - Healthcare data and clinical research provider IQVIA Holdings on Thursday forecast annual profit below Wall Street expectations, weighed down by higher interest costs, even as strong",
      "url": "https://finnhub.io/api/news?id=e765656a305790716ce0e8ee437a200beba2726e8e3a8a57cc67b8660c54a951"
    }
  },
  {
    "ts": null,
    "headline": "IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates",
    "summary": "IQVIA (IQV) delivered earnings and revenue surprises of +0.50% and +2.83%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=d131af549e8e5c85a7ad0fe03d4b7fe6e02f9e8ba6a4d543ac6afcda0b78c5a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770297302,
      "headline": "IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates",
      "id": 138364665,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "IQVIA (IQV) delivered earnings and revenue surprises of +0.50% and +2.83%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=d131af549e8e5c85a7ad0fe03d4b7fe6e02f9e8ba6a4d543ac6afcda0b78c5a8"
    }
  },
  {
    "ts": null,
    "headline": "IQVIA’s (NYSE:IQV) Q4 CY2025 Sales Top Estimates",
    "summary": "Clinical research company IQVIA (NYSE: IQV) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 10.3% year on year to $4.36 billion. The company’s full-year revenue guidance of $17.25 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $3.42 per share was 0.7% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=eca6f3ab3239d2674f5be4e14caa626ad94c9a7fbe5e8423143f8e2f67d97298",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770294972,
      "headline": "IQVIA’s (NYSE:IQV) Q4 CY2025 Sales Top Estimates",
      "id": 138363719,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "Clinical research company IQVIA (NYSE: IQV) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 10.3% year on year to $4.36 billion. The company’s full-year revenue guidance of $17.25 billion at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $3.42 per share was 0.7% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=eca6f3ab3239d2674f5be4e14caa626ad94c9a7fbe5e8423143f8e2f67d97298"
    }
  },
  {
    "ts": null,
    "headline": "IQVIA: Q4 Earnings Snapshot",
    "summary": "The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $3.40 per share. The clinical testing company posted revenue of $4.36 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $4.24 billion.",
    "url": "https://finnhub.io/api/news?id=09ef8a106944418308c8f70e94514f3f58dd4b4f295780d34b31ff4ec221e6f6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770294046,
      "headline": "IQVIA: Q4 Earnings Snapshot",
      "id": 138363720,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $3.40 per share. The clinical testing company posted revenue of $4.36 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $4.24 billion.",
      "url": "https://finnhub.io/api/news?id=09ef8a106944418308c8f70e94514f3f58dd4b4f295780d34b31ff4ec221e6f6"
    }
  },
  {
    "ts": null,
    "headline": "A Look At IQVIA Holdings (IQV) Valuation After Recent Share Price Volatility",
    "summary": "IQVIA Holdings (IQV) has been drawing attention after a period of weaker share performance, with the stock down around 14% over the past month and about 4% over the past 3 months. See our latest analysis for IQVIA Holdings. At a share price of US$202.54, IQVIA’s recent 7 day share price return of 15.52% and 30 day share price return of 13.66% sit against a year to date share price return of 10.13%, while the 1 year total shareholder return of 1.41% and 3 year total shareholder return of...",
    "url": "https://finnhub.io/api/news?id=dc59fe00d9357690b354006bf1c414ccc26dfa61995a516f8597117a9b5892df",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770286268,
      "headline": "A Look At IQVIA Holdings (IQV) Valuation After Recent Share Price Volatility",
      "id": 138362817,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IQV",
      "source": "Yahoo",
      "summary": "IQVIA Holdings (IQV) has been drawing attention after a period of weaker share performance, with the stock down around 14% over the past month and about 4% over the past 3 months. See our latest analysis for IQVIA Holdings. At a share price of US$202.54, IQVIA’s recent 7 day share price return of 15.52% and 30 day share price return of 13.66% sit against a year to date share price return of 10.13%, while the 1 year total shareholder return of 1.41% and 3 year total shareholder return of...",
      "url": "https://finnhub.io/api/news?id=dc59fe00d9357690b354006bf1c414ccc26dfa61995a516f8597117a9b5892df"
    }
  }
]